Speciality Chemicals Magazine MAR / APR 2026 | Page 37

PEPTIDES & PROTEINS
Figure 6- Bioassays linking peptide quality attributes to function
or measurement artefacts. Various techniques are available( Figure 3).
Size-exclusion chromatography( SEC) remains the workhorse for quantifying soluble aggregates. However, it can under-report species that are filtered out by the column frit, adsorb to the stationary phase or dissociate during the separation process, which is particularly relevant for large aggregates or peptides with concentration-dependent self-association.
Asymmetric flow field-flow fractionation( AF4), frequently paired with multi-angle light scattering( MALS), avoids a packed stationary phase and can resolve broader size distributions extending into the submicron range, making it ideal for characterising high-molecular-weight aggregates that might be filtered out or excluded by SEC.
Dynamic light scattering( DLS) supports rapid screening, but is intensity-weighted and can be dominated by small numbers of larger species. Sedimentation velocity analytical ultracentrifugation( SV- AUC) provides a matrix-free view in the as-formulated matrix and can quantify reversible self-association without column artefacts, making it a strong orthogonal complement to SEC and AF4 for peptides that display association behaviour, including at high concentration.
When SEC is paired with matrix-free techniques, irreversible aggregation can be distinguished from reversible self-association or chromatographic artefacts, clarifying whether an observation is formulationrelated or method-induced. Using independent analytical principles also increases confidence that aggregate quantification is not methoddependent and supports its scientific justification in regulatory contexts.
SV-AUC for aggregation
SV-AUC distinguishes reversible from irreversible aggregation by resolving species based on their sedimentation behaviour in free solution, without the column artefacts that complicate chromatographic methods. A key advantage of SV-AUC is operation in the as-formulated matrix, avoiding dilution, mobile-phase exchange and modifiers that can perturb concentrationdependent equilibria.
For low-molecular-weight peptides, conventional SV-AUC can be resolutionlimited. High-speed rotors extend the usable mass range and resolve small oligomers that otherwise sediment too slowly for reliable quantification. Micro-volume cells can reduce sample requirements to < 100 µ L when material is limited. Figure 4 shows some examples.
SV-AUC data are most persuasive when generated under GMP-aligned workflows with traceable data handling. Laboratories implementing validated software for AUC data extraction, storage, and reporting can support consistent batch-to-batch comparisons and audit-ready documentation.
Particulates across nm – mm continuum
Aggregation pathways can span a continuum from nanometre-scale oligomers to micrometre-scale particles and visible matter. For parenterals, sub-visible and visible particulates are both safety- and quality-relevant. Immunogenicity risk is multi-factorial and particles can contribute; accordingly, particulate control receives heightened scrutiny for injectables.
Compendial chapters such as USP < 788 > are useful reference points for particulate matter in injections and help frame baseline expectations. USP < 787 >, although written for therapeutic proteins, is often used as a risk-based template for qualifying alternative subvisible particle methods, supported by validation and justification.
Many programmes combine compendial counting with imaging to obtain morphological information and support root-cause analysis. Figure 5 shows a practical way to structure method selection by size regime:
• Sub-micron & soluble aggregate regime( nm to ~ 0.5 – 1 μm): SEC, AF4- MALS, DLS and SV-AUC provide complementary coverage.
• Sub-visible particles(~ 1 – 100 μm): Light obscuration( LO) provides established counts, while microflow imaging( MFI) and and related flow imaging methods provide morphology, transparency and aspect ratio information that can help distinguish peptide and protein particles from extrinsic matter. Because detection methods depend on optical properties and sizing assumptions, LO and flow imaging may diverge; using both reduces method-specific blind spots
• Visible particles(>~ 100 μm): Visual inspection remains the primary gatekeeper, supported by light microscopy
For root-cause work, Fouriertransform infrared( FTIR) microscopy
MAR / APR 2026 SPECCHEMONLINE. COM
37